Company Filing History:
Years Active: 2002
Title: Dan Dormady: Innovator in Polypeptide Modification
Introduction
Dan Dormady is a notable inventor based in Omaha, NE (US). He has made significant contributions to the field of biochemistry, particularly in the area of polypeptide modification. His innovative work has led to the development of a unique method that enhances the production of specific polypeptides.
Latest Patents
Dan Dormady holds a patent for "Clostripain catalyzed amidation of peptides." This invention provides a method of producing a polypeptide that features a C-terminal α-carboxamide group. The patent specifically addresses an enzymatic modification of selected substrate polypeptides, resulting in the cleavage of the substrate to form a product peptide with a C-terminal arginine residue that has an α-carboxamide group (C-terminal “Arg-NH”). The method involves contacting an aqueous-based solution containing an ammonia reagent and the substrate polypeptide with clostripain.
Career Highlights
Dan is currently associated with Bionebraska, Inc., where he continues to explore innovative solutions in biochemistry. His work has been instrumental in advancing the understanding and application of enzymatic processes in peptide synthesis.
Collaborations
Dan has collaborated with notable colleagues, including Jay S. Stout and Daniel J. Strydom. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Dan Dormady's contributions to the field of polypeptide modification exemplify the impact of innovative thinking in biochemistry. His patent and ongoing work at Bionebraska, Inc. highlight the importance of advancements in enzymatic processes.